The Buzz, Issue #6 is now available, featuring five new publications with high clinical relevance for Canadian allergists.

The Buzz Issue #6, August edition, will be sent to all HIVE members by email on Monday, July 26, and can be accessed online here. This edition covers:

  • Seroconversion following vaccination for patients on anti-CD20 therapy
  • Association between meconium metabolome and atopy in Canadian infants
  • Context for a network meta-analysis of antihistamines in chronic spontaneous urticaria
  • Case series and systematic review of omalizumab for idiopathic anaphylaxis
  • Review on allergic rhinitis management

To view all issues of The Buzz, go to thehivecommunity.org/the-buzz